When Warren Buffett disclosed his prostate cancer, the pundits from Bloomberg, CNBC, Forbes, Reuters, and Slate, among others, began a harsh comparison.
Which one got it right: Buffett, Berkshire Hathaway's CEO, or Steve Jobs, the late chief of Apple?
The waters surrounding CEO health are tricky to navigate, especially when dealing with the leader of a well-followed publicly held entity. It's trickier when a legend is involved. Fortunately, there's fiduciary responsibility that dictates what ought to be done.
We know ...